词条 | CGS-21680 |
释义 |
| Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 403602802 | ImageFile = CGS21680.png | IUPACName = 3-[4-[2-[ [6-amino-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]purin-2-yl]amino]ethyl]phenyl]propanoic acid | OtherNames = CGS 21680 |Section1={{Chembox Identifiers | CASNo_Ref = {{cascite|correct|??}} | CASNo = 120225-54-9 | PubChem = 3086599 | IUPHAR_ligand2 = 424 | IUPHAR_ligand = 375 | ChEBI_Ref = {{ebicite|changed|EBI}} | ChEBI = 73283 | ChEMBL_Ref = {{ebicite|correct|EBI}} | ChEMBL = 331372 | ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | ChemSpiderID = 2343185 | SMILES = O=C(O)CCc1ccc(cc1)CCNc2nc(c3ncn(c3n2)[C@@H]4O[C@H](C(=O)NCC)[C@@H](O)[C@H]4O)N | InChI = 1/C23H29N7O6/c1-2-25-21(35)18-16(33)17(34)22(36-18)30-11-27-15-19(24)28-23(29-20(15)30)26-10-9-13-5-3-12(4-6-13)7-8-14(31)32/h3-6,11,16-18,22,33-34H,2,7-10H2,1H3,(H,25,35)(H,31,32)(H3,24,26,28,29)/t16-,17+,18-,22+/m0/s1 | InChIKey = PAOANWZGLPPROA-RQXXJAGIBL | StdInChI_Ref = {{stdinchicite|changed|chemspider}} | StdInChI = 1S/C23H29N7O6/c1-2-25-21(35)18-16(33)17(34)22(36-18)30-11-27-15-19(24)28-23(29-20(15)30)26-10-9-13-5-3-12(4-6-13)7-8-14(31)32/h3-6,11,16-18,22,33-34H,2,7-10H2,1H3,(H,25,35)(H,31,32)(H3,24,26,28,29)/t16-,17+,18-,22+/m0/s1 | StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} | StdInChIKey = PAOANWZGLPPROA-RQXXJAGISA-N |Section2={{Chembox Properties | Formula = C23H29N7O6 | MolarMass = 499.52 | Appearance = | Density = | MeltingPt = | BoilingPt = | Solubility = |Section3={{Chembox Hazards | MainHazards = | FlashPt = | AutoignitionPt = }} CGS-21680 is a specific adenosine A2A subtype receptor agonist. It is usually presented as an organic hydrochloride salt with a molecular weight of 536.0 g/M. It is soluble up to 3.4 mg/mL in DMSO and 20 mg/mL in 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin. The chemical is currently used by researchers interested in studying neuronal transmission with a high-affinity, subtype specific analogue for adenosine. This includes research in respiration where it is believed that A2A receptors are involved in rhythm generation in the pre-Bötzinger complex. The drug is not currently approved for use in a therapeutic capacity. See also
References
4 : Nucleosides|Purines|Carboxamides|Adenosine receptor agonists |
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。